FDA approves Octapharma’s cutaquig® 16.5% for pediatric PI patients, providing flexible treatment options
EurekAlert!,
PARAMUS, N.J. (December 7, 2021) Octapharma USA today announced the U.S. Food
PARAMUS, N.J. (December 7, 2021) Octapharma USA today announced the U.S. Food
Dec. 7, 2021 15:03 UTC Families, Providers Can Utilize Flexible Infusion Schedule to Meet Patient Needs PARAMUS, N.J.--(BUSINESS…